ArticleDiabetes care2013

Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance.

William T Cefalu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.